8-K: Viewbix Inc. to Acquire Quantum AI, Secures $3M Funding

Viewbix Inc. has entered a non-binding agreement to acquire Quantum X Labs Ltd. for 65% of its capital stock and secured a $3.0 million private placement.

Summary

• Viewbix Inc. (the Company) signed a non-binding term sheet to acquire 100% of Quantum X Labs Ltd. (Quantum), a quantum computing and AI company.
• The acquisition consideration involves issuing 65.0% of Viewbix's post-closing capital stock to Quantum shareholders, comprising 19.99% Common Stock and the balance in pre-funded warrants.
• The Company also entered into a Securities Purchase Agreement for a private placement offering of 800,000 shares of Common Stock or pre-funded warrants, along with common warrants, at a combined price of $3.75 per share/warrant unit or $3.7499 per pre-funded warrant/warrant unit.
• The private placement is expected to generate approximately $3.0 million in gross proceeds, with an additional $4.5 million if common warrants are fully exercised in cash.
• The private placement securities include pre-funded warrants exercisable at $0.0001 per share (no expiry) and common warrants exercisable at $5.625 per share (expiring five years from issuance).
• A Registration Rights Agreement was signed, requiring Viewbix to file a resale registration statement for the private placement securities within 30 calendar days of the closing date and have it declared effective within 60-90 calendar days.
• The Company engaged L.I.A. Pure Capital Ltd. as an advisor for the private placement, agreeing to pay a $150,000 cash fee and issue a warrant to purchase 40,000 shares of Common Stock.
• Viewbix will also repay an outstanding loan of approximately $529,510 to L.I.A. Pure Capital Ltd.
• Both the acquisition and private placement are subject to due diligence, definitive agreements, regulatory approvals, and stockholder approval.

Sentiment

Score: 6

Explanation: The filing presents a significant strategic move (acquisition) and a capital raise, which are generally positive for growth. However, the non-binding nature of the acquisition, substantial potential dilution, and various closing conditions introduce considerable uncertainty and risk, balancing the positive aspects.

Positives

• Strategic acquisition of a "cutting-edge quantum computing and AI company" (Quantum X Labs Ltd.) could enhance Viewbix's technological capabilities and market position.
• The private placement secures approximately $3.0 million in gross proceeds, providing capital for general corporate purposes, including acquisitions and debt repayment.
• Potential for an additional $4.5 million in gross proceeds if common warrants are fully exercised in cash.
• The Registration Rights Agreement facilitates liquidity for investors in the private placement.

Negatives

• The acquisition is non-binding and subject to numerous conditions, including final due diligence, definitive agreements, regulatory approvals, and stockholder approval, indicating uncertainty.
• Significant dilution for existing shareholders as Quantum shareholders will receive 65.0% of Viewbix's post-closing capital stock.
• Further potential dilution from the exercise of 800,000 common warrants issued in the private placement and the 40,000 advisor warrants.
• The company is incurring advisory fees ($150,000 cash + 40,000 warrants) and repaying a $529,510 loan to the advisor, impacting net proceeds.
• The filing explicitly warns about forward-looking statements and potential non-occurrence of events, highlighting inherent risks.

Risks

• Failure to complete the acquisition due to unfulfilled conditions (due diligence, definitive agreements, regulatory approvals, stockholder approval).
• Significant dilution of existing shareholders' equity due to the issuance of 65.0% of post-closing capital stock for the acquisition and additional shares/warrants in the private placement.
• Market price volatility of Common Stock due to potential hedging activities by purchasers and future sales of registered securities.
• Inability to maintain listing on the Trading Market or comply with listing requirements.
• Potential for the SEC to review the registration statement, extending the effectiveness date.
• Risk of U.S. federal government or SEC shutdown delaying registration statement effectiveness.
• Company's inability to reserve sufficient Common Stock for warrant exercises, leading to pro-rata allocation.
• Legal and regulatory risks associated with securities offerings and corporate actions.

Future Outlook

The Company expects to close the Private Placement Offering and the Acquisition during December 2025, subject to various conditions. It will file a resale registration statement for the private placement securities within 30 days of closing and aims for effectiveness within 60-90 days. The Company intends to seek stockholder approval for the issuance of securities related to the private placement and acquisition at the next annual meeting in 2025 and plans to use net proceeds for general corporate purposes, including acquisitions and debt repayment.

Management Comments

• "The Company acknowledges that the issuance of the Securities may result in dilution of the outstanding shares of Common Stock, which dilution may be substantial under certain market conditions."
• "The Company further acknowledges that its obligations under the Transaction Documents, including, without limitation, its obligation to issue the Shares and Warrant Shares pursuant to the Transaction Documents, are unconditional and absolute and not subject to any right of set off, counterclaim, delay or reduction, regardless of the effect of any such dilution or any claim the Company may have against any Purchaser and regardless of the dilutive effect that such issuance may have on the ownership of the other stockholders of the Company."

Industry Context

The acquisition of a quantum computing and AI company suggests a strategic pivot or expansion into high-growth, cutting-edge technology sectors, aligning with broader industry trends towards AI and advanced computing. This could position Viewbix for future innovation and market relevance in these rapidly evolving fields.

Comparison to Industry Standards

• The acquisition consideration of 65% of the Company's post-closing capital stock for Quantum X Labs Ltd. is a substantial equity issuance, which could be higher than typical for strategic acquisitions depending on the target's valuation and growth prospects.
• The private placement pricing of $3.75 per unit (or $3.7499 for pre-funded) and common warrant exercise price of $5.625 suggests a premium over the current market price if the stock is trading below $5.625, or a discount if above. Without current market price, it's hard to assess.
• The advisory fee structure (cash plus warrants) is a common practice in private placements, but the specific amounts would need to be benchmarked against similar transactions for companies of comparable size and industry.
• The beneficial ownership limitation of 4.99% for warrant exercises is a standard anti-takeover or regulatory compliance measure.

Corporate Governance

Related Party Transactions

• The Company entered into an advisory agreement with L.I.A. Pure Capital Ltd. (Lead Investor) for the Private Placement Offering, agreeing to pay a $150,000 cash fee and issue a warrant for 40,000 shares of Common Stock.
• The Company will repay an outstanding loan of approximately $529,510 to L.I.A. Pure Capital Ltd. pursuant to an Amended and Restated Facility Agreement dated July 22, 2024.

Stakeholder Impact

• Shareholders: Significant potential dilution due to the issuance of 65.0% of post-closing capital stock for the acquisition and additional shares/warrants in the private placement. Potential for increased value if the acquisition of Quantum X Labs Ltd. proves successful.
• Investors in Private Placement: Will acquire shares and warrants at a specified price, with registration rights to facilitate resale.
• Quantum X Labs Ltd. Shareholders: Will become significant shareholders of Viewbix Inc., owning 65.0% of the combined entity.
• L.I.A. Pure Capital Ltd. (Advisor): Will receive a cash fee and warrants for advisory services, and an outstanding loan will be repaid.

Next Steps

• Complete final due diligence for the acquisition of Quantum X Labs Ltd.
• Execute definitive agreements for the acquisition.
• Obtain regulatory approvals for the acquisition.
• Obtain stockholder approval for the acquisition and the issuance of securities at the next annual meeting in 2025.
• Close the Private Placement Offering (expected December 2025).
• File a resale registration statement for the private placement securities within 30 calendar days after the Closing Date.
• Cause the registration statement to be declared effective within 60-90 calendar days after the Filing Date.
• Repay the outstanding loan of approximately $529,510 to L.I.A. Pure Capital Ltd.
• Maintain listing of Common Stock on the Trading Market and apply to list all Shares and Warrant Shares.

Key Dates

Recommendation

The strategic acquisition of a quantum computing and AI company presents a significant growth opportunity for Viewbix, potentially transforming its business. However, the non-binding nature of the acquisition, the substantial equity dilution for existing shareholders (65% of post-closing capital), and the various conditions precedent introduce considerable uncertainty. While the capital raise provides necessary funding, the immediate dilutive impact and the speculative nature of integrating a cutting-edge AI/quantum business warrant a cautious "Hold" stance. Investors should monitor the progress of the acquisition, the integration process, and the market's reaction to the combined entity's strategy before making further investment decisions.

Keywords

Quantum Computing, AI, Acquisition, Private Placement, Warrants, Common Stock, SEC Filing, Registration Rights, Dilution, Capital Raise, Viewbix Inc., Quantum X Labs Ltd.